K Német

843 total citations
12 papers, 692 citations indexed

About

K Német is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, K Német has authored 12 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in K Német's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). K Német is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). K Német collaborates with scholars based in Hungary, Netherlands and Czechia. K Német's co-authors include Dirk Roos, Futoshi Kuribayashi, Helen Middleton‐Price, Martin de Boer, C. Meischl, Anders Åhlin, Anthony W. Segal, Ewa Bernatowska, JP Hossle and Weening Rs and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and British Journal of Pharmacology.

In The Last Decade

K Német

11 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Német Hungary	6	328	231	185	106	81	12	692
B Y Rubin United States	9	509 1.6×	234 1.0×	138 0.7×	263 2.5×	61 0.8×	10	940
Curtis J. Henry United States	16	433 1.3×	272 1.2×	213 1.2×	112 1.1×	38 0.5×	49	887
Alice M. Wang United States	4	534 1.6×	463 2.0×	176 1.0×	157 1.5×	131 1.6×	7	1.1k
Katsuyuki Mitomo Japan	13	484 1.5×	434 1.9×	199 1.1×	76 0.7×	132 1.6×	20	984
Ilse Van Aelst Belgium	15	312 1.0×	301 1.3×	366 2.0×	128 1.2×	52 0.6×	24	1.1k
PM Guyre United States	7	343 1.0×	213 0.9×	91 0.5×	87 0.8×	34 0.4×	10	631
Hirokazu Hirata Japan	10	275 0.8×	589 2.5×	143 0.8×	35 0.3×	44 0.5×	14	834
JW Schrader Canada	8	478 1.5×	220 1.0×	122 0.7×	158 1.5×	74 0.9×	17	782
Oliver Feyen Germany	16	460 1.4×	250 1.1×	176 1.0×	118 1.1×	108 1.3×	32	841
James D. Alpers United States	7	464 1.4×	358 1.5×	196 1.1×	50 0.5×	71 0.9×	7	981

Countries citing papers authored by K Német

Since Specialization

Citations

This map shows the geographic impact of K Német's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Német with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Német more than expected).

Fields of papers citing papers by K Német

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Német. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Német. The network helps show where K Német may publish in the future.

Co-authorship network of co-authors of K Német

This figure shows the co-authorship network connecting the top 25 collaborators of K Német. A scholar is included among the top collaborators of K Német based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Német. K Német is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Özvegy‐Laczka, Csilla, Ágota Apáti, Mária Magócsi, et al.. (2009). Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties. British Journal of Pharmacology. 158(4). 1153–1164. 186 indexed citations

Nagy, Tünde, E. M. Molnar, Judit Jánossy, et al.. (2008). Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance. Annals of the Rheumatic Diseases. 68(7). 1201–1207. 57 indexed citations

Brózik, Anna, András Bors, Hajnalka Andrikovics, et al.. (2006). Reduction of Bcr‐Abl Function Leads to Erythroid Differentiation of K562 Cells via Downregulation of ERK. Annals of the New York Academy of Sciences. 1090(1). 344–354. 12 indexed citations

Rada, Balázs, Miklós Geiszt, Robin van Bruggen, et al.. (2003). Calcium signalling is altered in myeloid cells with a deficiency in NADPH oxidase activity. Clinical & Experimental Immunology. 132(1). 53–60. 36 indexed citations

Dérfalvi, Beáta, et al.. (1998). [The in vitro effect of recombinant human growth hormone on lymphocyte and granulocyte function in healthy and uremic children].. PubMed. 139(31). 1847–50. 1 indexed citations

Német, K, G Fekete, Douglas A. Schuler, et al.. (1997). [Chronic granulomatous disease (CGD): dysfunction of the neutrophil granulocyte NADPH-oxidase enzyme system].. PubMed. 138(7). 397–401. 1 indexed citations

Roos, Dirk, Martin de Boer, Futoshi Kuribayashi, et al.. (1996). Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 87(5). 1663–1681. 345 indexed citations

Német, K, et al.. (1992). When should granulocyte function be checked?. PubMed. 40(1). 59–63.

Czink, Elena, É Gyódi, K Német, & Susan R. Hollán. (1991). HLA antigens in Hungarian patients with idiopathic haemochromatosis.. Journal of Clinical Pathology. 44(1). 79–81. 4 indexed citations

10.

Német, K, et al.. (1987). Plasma lactoferrin levels in leukaemias. Clinical & Laboratory Haematology. 9(2). 137–145. 3 indexed citations

11.

Német, K, et al.. (1986). Relationship between maternal and infant iron stores: 1. Full term infants.. PubMed. 19(3). 197–205. 5 indexed citations

12.

Német, K, et al.. (1985). The biological role of lactoferrin.. PubMed. 18(1). 3–12. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact